Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q2 2025 · 10-Q
Revenue$0.00$0.00— vs Q2 2024 Net Income-$230.33K-$230.33KN/M vs Q2 2024 EPS Diluted$0.00$0.00— vs Q2 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
-$249,699
N/M
Operating Cash Flowderived$37,051N/M ended Jun 30, 2025 · filed Aug 13, 2025 · 44 d after period end